Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinephrine Dose Response in Healthy Volunteers
NCT02692313Phase 1Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jun 2016
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial (4 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Flow mediated dilation of the brachial artery at 240 minutes. Started Jun 2016; status: completed.
Beyond the preview
Go deeper on NCT02692313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02692313.